BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25271000)

  • 1. Differing coagulation profiles of patients with monoclonal gammopathy of undetermined significance and multiple myeloma.
    Crowley MP; Quinn S; Coleman E; Eustace JA; Gilligan OM; O'Shea SI
    J Thromb Thrombolysis; 2015 Feb; 39(2):245-9. PubMed ID: 25271000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
    Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
    Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet hyperactivation in multiple myeloma is also evident in patients with premalignant monoclonal gammopathy of undetermined significance.
    O'Sullivan LR; Meade-Murphy G; Gilligan OM; Mykytiv V; Young PW; Cahill MR
    Br J Haematol; 2021 Jan; 192(2):322-332. PubMed ID: 32478420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Thrombin Generation and Sensitivity to Activated Protein C Among Patients With Myeloma and Monoclonal Gammopathy of Undetermined Significance.
    Crowley MP; Kevane B; O'Shea SI; Quinn S; Egan K; Gilligan OM; Ní Áinle F
    Clin Appl Thromb Hemost; 2016 Sep; 22(6):554-62. PubMed ID: 26759370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study.
    Campbell JP; Heaney JLJ; Pandya S; Afzal Z; Kaiser M; Owen R; Child JA; Cairns DA; Gregory W; Morgan GJ; Jackson GH; Bunce CM; Drayson MT
    Lancet Haematol; 2017 Dec; 4(12):e584-e594. PubMed ID: 29146225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated protein C resistance as measured by residual factor V after Russell's viper venom and activated protein C treatment analyzed as a continuous variable in multiple myeloma and normal controls.
    Zangari M; Berno T; Zhan F; Boucher KM; Tricot G; Fink L
    Blood Coagul Fibrinolysis; 2011 Jul; 22(5):420-3. PubMed ID: 21537162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombotic abnormalities in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
    Nielsen T; Kristensen SR; Gregersen H; Teodorescu EM; Pedersen S
    Thromb Res; 2021 Jun; 202():108-118. PubMed ID: 33819778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with multiple myeloma and monoclonal gammopathy of undetermined significance have variably increased thrombin generation and different sensitivity to the anticoagulant effect of activated protein C.
    Ghansah H; Debreceni IB; Váróczy L; Rejtő L; Lóczi L; Bagoly Z; Kappelmayer J
    Thromb Res; 2023 Mar; 223():44-52. PubMed ID: 36708689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distortions but not Definitive Peaks by Capillary Serum Protein Electrophoresis Indicate Monoclonal Gammopathy of Undetermined Significance rather than Multiple Myeloma.
    Liang CA; Zhang L; Segal G; Dasgupta A; Nguyen AND; Wahed A
    Ann Clin Lab Sci; 2020 Jan; 50(1):151-152. PubMed ID: 32161026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
    Chang SH; Gumbel J; Luo S; Thomas TS; Sanfilippo KM; Luo J; Colditz GA; Carson KR
    Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2055-2061. PubMed ID: 31501149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of SE MRI and DWI of the spine in patients with monoclonal gammopathy of undetermined significance, smouldering myeloma and multiple myeloma.
    Dutoit JC; Vanderkerken MA; Anthonissen J; Dochy F; Verstraete KL
    Eur Radiol; 2014 Nov; 24(11):2754-65. PubMed ID: 25106487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global coagulation assays in patients with multiple myeloma and monoclonal gammopathy of unknown significance.
    Lim HY; Brook R; Krishnamoorthi B; Tacey M; Leung T; Donnan G; Nandurkar H; Ho P
    Thromb Res; 2019 Nov; 183():45-48. PubMed ID: 31669660
    [No Abstract]   [Full Text] [Related]  

  • 14. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma.
    Wadhera RK; Kyle RA; Larson DR; Dispenzieri A; Kumar S; Lazarus HM; Rajkumar SV
    Blood; 2011 Sep; 118(11):2985-7. PubMed ID: 21765020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood lymphocyte subsets in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Tienhaara A; Pelliniemi TT
    Clin Lab Haematol; 1994 Sep; 16(3):213-23. PubMed ID: 7828409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercoagulability in multiple myeloma and its precursor state, monoclonal gammopathy of undetermined significance.
    Kristinsson SY; Björkholm M; Schulman S; Landgren O
    Semin Hematol; 2011 Jan; 48(1):46-54. PubMed ID: 21232658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.